Empowered Patient Podcast

Maina Bhaman, Partner, Capital Funds, Sofinnova Partners has a long record as a successful healthcare investor in oncology, hearing, cardiovascular and cell and gene therapy. She talks about their recent investments in Myricx Pharma, a startup from Imperial College and the Francis Crick Institute in London focused on inhibiting the NMT enzyme to kill MYC-driven cancer cells and Catamaran Bio focusing on CAR-NK cells to kill solid tumors by addressing the tumor microenvironment. #SofinnovaPartners #Biotech #Funding #CARNK #Cancer SofinnovaPartners.com Download the transcript here